Childen's Hospital Boston  300 Longwood Avenue
Boston, MA 02115
(617) 355-6000
 X
Clinical Services (Hodgkin's Lymphoma Program):
Research & Clinical Trials
Dana-Farber Cancer Institute is a founding member of a small national consortium of leading medical centers that investigates new treatments for children with Hodgkin's disease. Through this consortium, Dana-Farber/Children's Hospital Cancer Care (DF/CHCC) physicians are investigating new drug combinations that deliver good results with fewer long-term complications. Currently, we are accruing patients for a research study investigating treatment for low-risk and advanced Hodgkin's disease.

In addition, DF/CHCC offers access to all Children's Oncology Group's Phase I clinical trials and other trials for relapsed Hodgkin's.

If you are interested in learning about our clinical trials, visit our online listing or contact our New Patient Coordinator at 1-888-PEDI-ONC.

Dana-Farber/Children's Hospital Cancer Care
 X
 X The information on this website should not be taken as medical advice,
which can only be given to you by your personal health care professional.
 X
 X Copyright © Children's Hospital Boston. All rights reserved.